Dyadic Applied BioSolutions (NASDAQ: DYAI) is focused on leveraging advanced microbial and protein expression technologies to support the development and manufacture of biopharmaceuticals, vaccines, and other biologic products. The company’s proprietary technology platforms are designed to improve production efficiency and support innovation across life sciences applications.

Topics discussed include the company’s technology platform, business strategy, growth initiatives, market opportunities, and long-term outlook.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.